New research from China's Kunming Institute of Botany reveals that roasted Arabica coffee beans contain compounds that might aid in managing blood sugar levels, particularly for type 2 diabetes. The study highlights three specific compounds that inhibit the α-glucosidase enzyme, which is a target for some diabetes medications. While coffee is not a treatment for diabetes, these findings contribute to a growing body of evidence suggesting that coffee can positively influence blood sugar control.
• The research focused on roasted Arabica coffee beans from Yunnan province.
• Scientists extracted compounds from the beans and found three that slow down the α-glucosidase enzyme.
• Previous studies indicate that both caffeinated and decaffeinated coffee may lower type 2 diabetes risk by 20-30%.
• More research is needed to understand how these compounds affect humans and their presence in brewed coffee.
Understanding the potential health benefits of coffee could reshape dietary recommendations. While it is not a substitute for medical treatment, this research opens doors for future studies on how natural food compounds can support diabetes management.
Enjoying the read? Subscribe for free to one of the fastest-growing newsletters and get weekly coffee news (TL;DR updates) delivered right to your inbox.